Global Reduction of H3K4me3 Improves Chemotherapeutic Efficacy for Pediatric Ependymomas
BACKGROUND: Ependymomas (EPNs) are the third most common brain tumor in children. These tumors are resistant to available chemotherapeutic treatments, therefore new effective targeted therapeutics must be identified. Increasing evidence shows epigenetic alterations including histone posttranslationa...
Main Authors: | Rebecca Lewis, Yuping D Li, Lindsey Hoffman, Rintaro Hashizume, Gordan Gravohac, Gavin Rice, Nitin R Wadhwani, Chunfa Jie, Tatiana Pundy, Barbara Mania-Farnell, Chandra S Mayanil, Marcelo B Soares, Ting Lei, Charles D James, Nicolas K Foreman, Tadanori Tomita, Guifa Xi |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2019-06-01
|
Series: | Neoplasia: An International Journal for Oncology Research |
Online Access: | http://www.sciencedirect.com/science/article/pii/S1476558619300752 |
Similar Items
-
Therapeutic Potential for Bone Morphogenetic Protein 4 in Human Malignant Glioma
by: Guifa Xi, et al.
Published: (2017-04-01) -
Identification of microRNAs as potential prognostic markers in ependymoma.
by: Fabricio F Costa, et al.
Published: (2011-01-01) -
Supratentorial tanycytic ependymoma: an uncommon fibrillary ependymoma variant
by: Fabiano Reis, et al.
Published: (2011-08-01) -
Clinical association analysis of ependymomas and pilocytic astrocytomas reveals elevated FGFR3 and FGFR1 expression in aggressive ependymomas
by: Birgitta Lehtinen, et al.
Published: (2017-05-01) -
PI3K/AKT Pathway and Brain Malformations
by: Gavin B. Rice, et al.
Published: (2015-07-01)